The Current State of Critical Limb Ischemia: A... (2016 study) Skip to main content
Systematic Review JAMA Surg 2016

The Current State of Critical Limb Ischemia: A Systematic Review

Farber A, Eberhardt R, JAMA Surg, 2016

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

The authors reviewed published medical articles from 1980 to 2016 to describe what is known about how common critical limb ischemia is, what causes it, how it is diagnosed, and how it is treated.

What They Found

This systematic review of English-language articles found that critical limb ischemia is the end stage of peripheral arterial disease, and that revascularization (restoring blood flow) is the cornerstone of therapy to prevent limb amputation. Peripheral arterial disease is most commonly caused by atherosclerosis, so the condition is heavily associated with smoking and diabetes. Both open vascular surgery and endovascular therapy play a key role in treatment. However, few scientific data are available to show which revascularization strategy is best, which has led to a lot of variability and equipoise in how the condition is treated. Medical therapy helps optimize other cardiovascular risk factors but has only a limited role in improving limb outcomes when revascularization is not possible. The abstract describes the condition as highly morbid, with a high risk of limb loss and death.

What This Means for Canadian Patients

The abstract does not mention hyperbaric oxygen therapy, so it does not address HBOT. It covers only critical limb ischemia in general: surgery and endovascular treatment are central, and the best approach between them is not settled. Patients with this condition should talk with a vascular specialist about their treatment options.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract states that few scientific data exist to identify the best revascularization strategy, and it reports no sample size or pooled statistics, so it gives no numbers to compare treatments.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Systematic Review
Category Systematic Reviews
Source Pubmed
PubMed ID 27551978
Year Published 2016
Journal JAMA Surg
MeSH Terms Amputation, Surgical; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Humans; Hyperbaric Oxygenation; Hyperlipidemias; Hypertension; Ischemia; Lower Extremity; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Smoking; Smoking Cessation; Upper Extremity

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology